Tower Research Capital (TRC)’s Nuveen Short-Term REIT ETF NURE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $393K | Sell |
14,443
-6,856
| -32% | -$196K | 0.01% | 1103 |
|
|
2025
Q4 | $600K | Sell |
21,299
-926
| -4% | -$26K | 0.01% | 739 |
|
|
2025
Q3 | $640K | Buy |
22,225
+2,763
| +14% | +$81.1K | 0.02% | 715 |
|
|
2025
Q2 | $577K | Sell |
19,462
-4,054
| -17% | -$121K | 0.02% | 863 |
|
|
2025
Q1 | $735K | Buy |
23,516
+6,961
| +42% | +$219K | 0.02% | 644 |
|
|
2024
Q4 | $526K | Sell |
16,555
-1,128
| -6% | -$37.3K | 0.01% | 1022 |
|
|
2024
Q3 | $600K | Sell |
17,683
-11,926
| -40% | -$391K | 0.02% | 758 |
|
|
2024
Q2 | $921K | Buy |
29,609
+8,373
| +39% | +$253K | 0.02% | 824 |
|
|
2024
Q1 | $650K | Sell |
21,236
-5,067
| -19% | -$153K | 0.02% | 719 |
|
|
2023
Q4 | $812K | Sell |
26,303
-1,991
| -7% | -$55.5K | 0.01% | 1002 |
|
|
2023
Q3 | $768K | Sell |
28,294
-860
| -3% | -$25.3K | 0.02% | 653 |
|
|
2023
Q2 | $887K | Sell |
29,154
-1,784
| -6% | -$53.5K | 0.03% | 581 |
|
|
2023
Q1 | $920K | Buy |
30,938
+3,681
| +14% | +$111K | 0.03% | 495 |
|
|
2022
Q4 | $775K | Buy |
27,257
+4,986
| +22% | +$147K | 0.03% | 485 |
|
|
2022
Q3 | $662K | Sell |
22,271
-12,012
| -35% | -$403K | 0.01% | 925 |
|
|
2022
Q2 | $1.1M | Buy |
34,283
+30,462
| +797% | +$1.09M | 0.02% | 631 |
|
|
2022
Q1 | $149K | Buy |
3,821
+2,726
| +249% | +$104K | ﹤0.01% | 1949 |
|
|
2021
Q4 | $45K | Sell |
1,095
-3,288
| -75% | -$125K | ﹤0.01% | 2844 |
|
|
2021
Q3 | $155K | Sell |
4,383
-23,749
| -84% | -$855K | ﹤0.01% | 2044 |
|
|
2021
Q2 | $955K | Buy |
28,132
+8,591
| +44% | +$281K | 0.02% | 694 |
|
|
2021
Q1 | $590K | Sell |
19,541
-28,944
| -60% | -$825K | 0.01% | 1101 |
|
|
2020
Q4 | $1.31M | Buy |
48,485
+39,180
| +421% | +$998K | 0.04% | 372 |
|
|
2020
Q3 | $214K | Sell |
9,305
-31,796
| -77% | -$736K | ﹤0.01% | 2519 |
|
|
2020
Q2 | $936K | Sell |
41,101
-51,108
| -55% | -$1.15M | 0.04% | 570 |
|
|
2020
Q1 | $1.94M | Buy |
92,209
+85,502
| +1,275% | +$2.38M | 0.12% | 106 |
|
|
2019
Q4 | $203K | Sell |
6,707
-6,445
| -49% | -$197K | 0.02% | 575 |
|
|
2019
Q3 | $405K | Sell |
13,152
-2,376
| -15% | -$71.4K | 0.03% | 663 |
|
|
2019
Q2 | $451K | Buy |
15,528
+2,640
| +20% | +$76.7K | 0.03% | 512 |
|
|
2019
Q1 | $368K | Sell |
12,888
-15,574
| -55% | -$429K | 0.02% | 802 |
|
|
2018
Q4 | $711K | Buy |
28,462
+10,680
| +60% | +$283K | 0.05% | 334 |
|
|
2018
Q3 | $484K | Sell |
17,782
-20,720
| -54% | -$570K | 0.04% | 488 |
|
|
2018
Q2 | $1.05M | Sell |
38,502
-1,908
| -5% | -$49.7K | 0.06% | 336 |
|
|
2018
Q1 | $967K | Buy |
40,410
+31,531
| +355% | +$783K | 0.08% | 203 |
|
|
2017
Q4 | $231K | Buy |
+8,879
| New | +$236K | 0.03% | 512 |
|
Other funds holding NURE
CWM
KW
SWTS
Tower Research Capital (TRC)'s NURE Position: Q1 2026 in Review
Tower Research Capital (TRC) reduced its Nuveen Short-Term REIT ETF (NURE) stake by 32% in Q1 2026, selling an estimated $196K and leaving 14,443 shares worth $393K. The position accounts for 0.01% of the portfolio, ranked #1103.
Tower Research Capital (TRC) first reported a position in NURE in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.94M in Q1 2020. 31 funds tracked by Wall St. Rank hold NURE as of Q1 2026.
- Tower Research Capital (TRC) held 14,443 shares of Nuveen Short-Term REIT ETF worth $393K as of Q1 2026.
- Tower Research Capital (TRC) sold 6,856 Nuveen Short-Term REIT ETF shares in Q1 2026, an estimated $196K.
- Nuveen Short-Term REIT ETF made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1103 holding.
- Tower Research Capital (TRC) first reported a position in Nuveen Short-Term REIT ETF in Q4 2017 and has held it in 34 quarters since.
- Tower Research Capital (TRC)'s Nuveen Short-Term REIT ETF position peaked at $1.94M in Q1 2020.
- 31 funds tracked by Wall St. Rank held Nuveen Short-Term REIT ETF as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.